Biliary laryngopharyngeal reflux: A new pathological entity

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 14, Issue 3, 2006, Pages 128-132

  Galli, Jacopo ^a   Cammarota, Giovanni ^a   De Corso, Eugenio ^a,b   Agostino, Stefania ^a   Cianci, Rossella ^a   Almadori, Giovanni ^a   Paludetti, Gaetano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Duodeno gastro esophageal reflux; Gastrectomy; Laryngeal cancer

Indexed keywords

BILE ACID; CYCLOOXYGENASE 2; PROSTAGLANDIN SYNTHASE; TRYPSIN;

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; BILE REFLUX; BILIARY LARYNGOPHARYNGEAL REFLUX; CANCER RISK; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DUODENOGASTRIC REFLUX; ESOPHAGITIS; EXPERIMENTAL MODEL; GASTRECTOMY; GASTRECTOMY BILLROTH I; GASTRITIS; GASTRODUODENOSTOMY; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNGOPHARYNGEAL REFLUX; LARYNX CANCER; LARYNX INJURY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PYLOROPLASTY; REVIEW; RISK ASSESSMENT; ROUX Y ANASTOMOSIS; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH ULCER; TOTAL STOMACH RESECTION; TREATMENT INDICATION;

BILE; GASTROESOPHAGEAL REFLUX; HUMANS; HYPOPHARYNX; LARYNGEAL DISEASES; PHARYNGEAL DISEASES;

EID: 33744949213     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000193198.40096.be     Document Type: Review

References (27)

1. Ozlugedik S, Yorulmaz I, Gokcan K. Is laryngopharyngeal reflux an important risk factor in the development of laryngeal carcinoma? Eur Arch Otorhinolaryngol 2005 :27.
2. Qadeer MA, Colabianchi N, Vaezi MF. Is GERD a risk factor for laryngeal cancer? Laryngoscope 2005; 115:486-491. A meta-analysis that suggests that GERD may be a significant risk factor for laryngeal cancer.
3. Sasaki CT, Marotta J, Hundal J, et al. Bile-induced laryngitis: is there a basis in evidence? Ann Otol Rhinol Laryngol 2005; 114:192-197. In this paper the authors constructed a saline-controlled rat model demonstrating for the first time that bile acids can be topically injurious to intact laryngeal mucosa.
4. Galli J, Cammarota G, Calo L, et al. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma. Laryngoscope 2002; 112:1861-1865.
5. Galli J, Calo L, Agostino S, et al. Bile reflux as possible risk factor in laryngopharyngeal inflammatory and neoplastic lesions. Acta Otorhinolaryngol Ital 2003; 23:377-382.
6. Cianci R, Galli J, Agostino S, et al. Gastric surgery as a long-term risk factor for malignant lesions of the larynx. Arch Surg 2003; 138:751-754.
7. Cammarota G, Galli J, Cianci R, et al. Association of laryngeal cancer with previous gastric resection. Ann Surg 2004; 240:817-824.
8. Vaezi MF, Richter JE. Importance of duodenogastroesophageal reflux in the medical outopatient practice. Hepatogastroenterol 1999; 46:40-47.
9. Zhang C, Liu ZK, Yu PW. Effects of bile reflux and intragastric microflora changes on lesions of remnant gastric mucosa after gastric operation. World J Gastroenterol 2004; 15 (10):1537-1539 (10).
10. Jaiswal K, Lopez-Guzman C, Souza RF, et al. Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line. Am J Physiol Gastrointest Liver Physiol 2006; 290 (2) (G335-42. Epub 2005 Oct 20).
11. Kauer WK, Stein HJ. Bile reflux in the constellation of gastroesophageal reflux disease. Thorac Surg Clin 2005; 15:335-340.
12. Ishikawa M, Kitayama J, Kaizaki S, et al. Prospective randomized trial comparing Billroth I and Roux-en-Y procedures after distal gastrectomy for gastric carcinoma. World J Surg 2005; 29:1415-1420.
13. Cheng BC, Xia J, Shao K, et al. Surgical treatment for upper or middle esophageal carcinoma occurring after gastrectomy: a study of 52 cases. Dis Esophagus 2005; 18:239-245.
14. Sears RJ, Champion GL, Richter JE. Role of acid and duodeno-gastric reflux in oesophageal symptoms of duodeno-gastric reflux. Am J Gastroenterol 2004; 99:2098-2106.
15. Richter JE. Duodenogastric reflux-induced (alkaline). Esophagitis Curr Treat Options Gastroenterol 2004; 7:53-58.
16. Imada T, Chen C, Hatori S, et al. Effect of trypsin inhibitor on reflux esophagitis after total gastrectomy in rats. Eur J Surg 1999; 165:1045-1050.
17. Jang TJ, Min SK, Bae JD, et al. Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux. Gut 2004; 53:27-33.
18. Hayakawa T, Fujiwara Y, Hamaguchi M, et al. Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 in rat acid reflux oesophagitis. Gut 2006; 55:450-456.
19. Jolly AJ, Wild CP, Hardie LJ. Acid and bile salts induce DNA damage in human oesophageal cell lines. Mutagenesis 2004; 19:319-324.
20. Lorusso D, Linsalata M, Pezzolla F, et al. Duodenogastric reflux and gastric mucosa polyamines in the non-operated stomach and in the gastric remnant after Billroth II gastric resection. A role in gastric carcinogenesis? Anticancer Res 2000; 20:2197-2201.
21. Sung MW, Roh JL, Park BJ, et al. Bile acid induces Cyclo-Oxygenase-2 expression in cultured human pharyngeal cells: a possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux. Laryngoscope 2003; 113:1059-1063.
22. Adhami T, Goldblum JR, Richter JE, Vaezi MF. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol 2004; 99:2098-2106.
23. Richter JE. Review article: extraoesophageal manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005; 22 (Suppl 1):70-80. A comprehensive review, emphasizing recent literature, that addresses the controversial topic of the cause-and-effect relationship between GERD and ear, nose and throat and respiratory diseases and the diagnosis procedures.
24. Tack J, Koek G, Demedts I, et al. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both? Am J Gastroenterol 2004; 99:981-988.
25. Tack J. Review article: role of pepsin and bile in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005; 22 (Suppl 1):48-54 (Review). A comprehensive review, emphasizing recent literature, that addresses the relationship between persist reflux symptoms during acid suppressive therapy and nonacid reflux events. The authors discuss the therapeutic options for the non-acid component of the refluxate.
26. Williams RB, Szczesniak MM, Maclean JC, et al. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis. Am J Gastroenterol 2004; 99:777-785.
27. Nishijima K, Miwa K, Miyashita T, et al. Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg 2004; 240:57-67.